| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 15.447 | 18.780 | 20.220 | 36.228 | 43.343 | 42.874 | 56.519 | 58.980 | 77.620 | 89.174 |
| Total Income - EUR | 15.448 | 18.780 | 20.221 | 36.229 | 43.407 | 45.977 | 56.521 | 58.982 | 77.622 | 107.951 |
| Total Expenses - EUR | 9.978 | 17.072 | 18.595 | 25.666 | 31.966 | 33.103 | 27.571 | 40.337 | 46.388 | 70.091 |
| Gross Profit/Loss - EUR | 5.470 | 1.708 | 1.625 | 10.563 | 11.441 | 12.874 | 28.950 | 18.645 | 31.234 | 37.859 |
| Net Profit/Loss - EUR | 5.007 | 1.520 | 1.423 | 10.201 | 11.007 | 12.477 | 28.424 | 18.096 | 30.574 | 35.467 |
| Employees | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 3 | 2 |
Check the financial reports for the company - Florypopmed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 8.995 | 6.050 | 4.075 | 1.163 | 1.085 | 1.423 | 1.082 | 4.003 | 4.595 |
| Current Assets | 5.571 | 4.020 | 4.114 | 14.644 | 19.024 | 23.671 | 33.859 | 24.467 | 57.409 | 46.509 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 4.021 |
| Receivables | 1.266 | 1.556 | 1.507 | 3.360 | 3.595 | 3.669 | 3.864 | 5.707 | 32.043 | 428 |
| Cash | 4.304 | 2.464 | 2.607 | 11.283 | 15.429 | 20.002 | 29.995 | 18.760 | 25.366 | 42.060 |
| Shareholders Funds | 3.048 | 4.537 | 5.884 | 15.976 | 16.671 | 18.033 | 33.929 | 23.741 | 40.092 | 45.180 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 2.522 | 8.478 | 4.281 | 2.743 | 3.516 | 6.723 | 1.353 | 1.808 | 2.384 | 5.857 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 18.936 | 67 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8621 - 8621" | |||||||||
| CAEN Financial Year |
8621
|
|||||||||
Comments - Florypopmed Srl